晶泰控股(02228.HK)擬折讓7.8%配股 淨籌26.3億元
晶泰控股(02228.HK)公布,擬配售最多2.86億股新股,佔擴大後已發行股本約6.64%,每股配售價9.28元,較昨日(28日)收市價每股10.06元折讓約7.75%。
公司預期配售所得款項淨額約為為26.3億元,擬用於產品持續迭代升級,提升研發技術能力和解決方案能力;產品商業化及業務發展,加強與從事於與集團類似及互惠互利行業的外部各方及合作夥伴的業務合作,擴大公司的規模及市場份額;潛在機會收購及投資、人才吸引與引進、營運資金補充和一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.